The secondary endpoints include the amount and percent rate of change in eGFR from baseline to week @ , the amount and percent rate of change in SUA concentration from baseline to week @ , the proportion of patients who achieved an SUA concentration@ @ mg/dL , and the incidence of renal function deterioration .